News for Healthier Living

Novel CAR T Cell Therapy Developed by UT MD Anderson Researchers Moves Into Clinical Studies

The University of Texas MD Anderson Cancer Center and CTMC, a joint venture between UT MD Anderson and Resilience, today announced that the Food and Drug Administration (FDA) has issued a 'safe to proceed' for the Investigational New Drug (IND) application for a novel chimeric antigen receptor (CAR) T cell therapy.

May 15, 2026


May 15 2026

May 14 2026

May 13 2026

May 12 2026

May 11 2026

May 10 2026

May 8 2026

May 7 2026

May 6 2026

May 5 2026

May 4 2026